# Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

> **NCT00174317** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 250 (—)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT00174317
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 250 (—)
- **Last updated:** 2006-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174317, "Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00174317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*